Bicycle Therapeutics
Employee Participants0
Total Rating0
Revenue$0
Developer of first in class medicines created to treat cancer and other debilitating diseases. The company's first in class medicines includes bicyclic peptides that combine antibody-like affinity and selectivity with small molecule-like tissue penetration, tuneable exposure, flexible pharmacokinetics and chemical synthesis, exploring the potential of bicyclic peptides as targeted, titratable and rapidly penetrant immunomodulators, overcoming the challenges seen for other agents with long exposure, irreversible effects and attendant toxicities. Read More
Headquarters Meditrina Building, Cambridge, CB22 3AT, GBR
Website www.bicycletherapeutics.com